Inhibition of caspase cascade by HTLV-I tax through induction of NF-κB nuclear translocation

Blood

Volumn 94, Issue 11, 1999, Pages 3847-3854

  Kawakami, Atsushi ^a,b   Nakashima, Tomoki ^a   Sakai, Hideaki ^a   Urayama, Satoshi ^a   Yamasaki, Satoshi ^a   Hida, Ayumi ^a   Tsuboi, Masahiko ^a   Nakamura, Hideki ^a   Ida, Hiroaki ^a   Migita, Kiyoshi ^a   Kawabe, Yojiro ^a   Eguchi, Katsumi ^a  

^a NAGASAKI UNIVERSITY   (Japan)

^b NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; VIRUS VECTOR;

APOPTOSIS; ARTICLE; CELL NUCLEUS; CELL PROLIFERATION; CYTOKINE PRODUCTION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS INFECTION; INTRACELLULAR TRANSPORT; LEUKEMIA CELL LINE; PRIORITY JOURNAL; PROTEIN INDUCTION; PROTEIN TARGETING;

EID: 0033485652     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v94.11.3847.423a24_3847_3854     Document Type: Article

References (38)

1. Wano Y, Hattori T, Matsuoka M, Takatsuki K, Chua AO, Gunler U, Greene WC: Interleukin 1 gene expression in adult T-cell leukemia. J Clin Invest 80:911, 1987
2. Maruyama M, Shibuya H, Harada H, Hatakeyama M, Seiki M, Fujita T, Inoue J, Yoshida M, Taniguchi T: Evidence for aberrant activation of the interleukin-2 autocrine loop by HTLV-I-encoded p40x and T3/Ti complex triggering. Cell 48:343, 1987
3. Siekevitz M, Feinberg MB, Holbrook N, Wong-Staal F, Greene WC: Activation of interleukin-2 and interleukin-2 receptor (Tac) promoter expression by the trans-activator (tat) gene product of human T-cell leukemia virus type I. Proc Natl Acad Sci USA 84:5389, 1987
4. Sakai M, Eguchi K, Terada K, Nakashima M, Yamashita I, Ida H, Kawabe Y, Aoyagi T, Takino H, Nakamura T, Nagataki S: Infection of human synovial cells by human T-cell lymphotropic virus Type I; proliferation and granulocyte/macrophage colony-stimulating factor production by synovial cells. J Clin Invest 92:1957, 1993
5. Baeuerle PA, Henkel T: Function and activation of NF-κB in the immune system. Annu Rev Immunol 12:141, 1994
6. Yamashita I, Katamine S, Moriuchi R, Nakamura Y, Miyamoto T, Eguchi K, Nagataki S: Transactivation of the human interleukin-6 gene by human T-lymphotropic virus type 1 Tax protein. Blood 84:1573, 1994
7. Osame M, Matsumoto M, Usuku K, Izumo S, Ijichi N, Amitani H, Tara M, Igata A: Chronic progressive myelopathy associated with elevated antibodies to human T-lymphotropic virus type I and adult T-cell leukemia-like cells. Ann Neurol 21:117, 1987
8. Eguchi K, Matsuoka N, Ida H, Nakashima M, Sakai M, Sakito S, Kawakami A, Terada H, Shimada H, Kawabe Y, Fukuda T, Sawada T, Nagataki S: Primary Sjögren's syndrome with antibodies to HTLV-I: Clinical and laboratory features. Ann Rheum Dis 51:769, 1992
9. Terada K, Katamine S, Eguchi K, Moriuchi R, Kita M, Shimada H, Yamashita I, Iwata K, Tsuji Y, Nagataki S, Miyamoto T: Prevalence of serum and salivary antibodies to HTLV-I in Sjögren's syndrome. Lancet 344:1116, 1994
10. Eguchi K, Origuchi T, Takashima H, Iwata K, Katamine S, Nagataki S: High seroprevalence of anti-HTLV-I antibody in rheumatoid arthritis. Arthritis Rheum 39:463, 1996
11. Nakamura H, Eguchi K, Nakamura T, Mizokami A, Shirabe S, Kawakami A, Matsuoka N, Migita K, Kawabe Y, Nagataki S: High prevalence of Sjögren's syndrome in patients with HTLV-I associated myelopathy. Ann Rheum Dis 56:167, 1997
12. Beg AA, Baltimore D: An essential role for NF-κB in preventing TNF-α-induced cell death. Science 274:782, 1996
13. Liu Z-G, Hsu H, Goeddel D, Karin M: Dissection of TNF receptor 1 effector function: JNK activation is not linked to apoptosis while NF-κB activation prevents cell death. Cell 87:565, 1996
14. Wang C-Y, Mayo MW, Balwin Jr AS: TNF-and cancer therapy-induced apoptosis: Potentiation by inhibition of NF-κB. Science 274:784, 1996
15. Van Antwerp DJ, Martin SJ, Kafri T, Green DR, Verma IM: Suppression of TNF-α-induced apoptosis by NF-κB. Science 274:787, 1996
16. Baeuerle PA, Baltimore D: NF-κB: Ten years after. Cell 87:13, 1996
17. Nagata S: Apoptosis by death factor. Cell 88:355, 1997
18. Wang C-Y, Mayo MW, Korneluk RG, Goeddel DV, Baldwin Jr AS: NF-κB antiapoptosis: Induction of TRAF1 and TRAF2 and c-IAP1 and C-IAP2 to suppress caspase-8 activation. Science 281:1680, 1998
19. Stehlik C, Martin R, Kumabayashi I, Schmid JA, Binder BR, Lipp J: Nuclear factor (NF)-κB-regulated X-chromosome-linked iap gene expression protects endothelial cells from tumor necrosis factor α-induced apoptosis. J Exp Med 188:211, 1998
20. Hiraiwa N, Hiraiwa M, Kannagi R: Human T-cell leukemia virus-1 encoded Tax protein transactivates α1 → 3 fucosyltransferase Fuc-T VII, which synthesizes sialyl lewis X, a selectin ligand expressed on adult T-cell leukemia cells. Biochem Biophys Res Commun 231:183, 1997
21. Ozaki K, Takeda H, Iwahashi H, Kitano S, Hanazawa S: NF-κB inhibitors stimulate apoptosis of rabbit mature osteoclasts and inhibit bone resorption by these cells. FEBS Lett 410:297, 1997
22. Miagkov AV, Kovalenko DV, Brown CE, Didsbury JR, Cogswell JP, Stimpson SA, Baldwin AS, Makarov SS: NF-κB activation provides the potential link between inflammation and hyperplasia in the arthritic joint. Proc Natl Acad Sci USA 95:13859, 1998
23. Kawakami A, Eguchi K, Matsuoka N, Tsuboi M, Koji T, Urayama S, Fujiyama K, Kiriyama T, Nakashima T, Nakane PK, Nagataki S: Fas and Fas ligand interaction is necessary for human osteoblast apoptosis. J Bone Miner Res 12:1637, 1997
24. Enari M, Talanian RV, Wong WW, Nagata S: Sequential activation of ICE-like and CPP32-like proteases during Fas-mediated apoptosis. Nature 380:723, 1996
25. Cui H, Matsui K, Omura S, Schauer SL, Matulka RA, Sonenshein GE, Ju S-T: Proteasome regulation of activation-induced T cell death. Proc Natl Acad Sci USA 94:7515, 1997
26. Scaffidi C, Medema JP, Krammer PH, Peter ME: FLICE is predominantly expressed as two functionally active isoforms, caspase-8/a and caspase-8/b. J Biol Chem 272:26953, 1997
27. Boussiotis VA, Lee BJ, Freeman GJ, Gribben JG, Nadler LM: Induction of T-cell clonal anergy results in resistance, whereas CD28-mediated costimulation primes for susceptibility to Fas-and Bax-mediated programmed cell death. J Immunol 159:3156, 1997
28. Deveraux QL, Roy N, Stennicke HR, Arsdale TV, Zhou Q, Srinivasula SM, Alnemri ES, Salvesen GS, Reed JC: IAPs block apoptotic events by caspase-8 and cytochrome c by direct inhibition of distinct caspases. EMBO J 17:2215, 1998
29. Medema JP, Scaffidi C, Kischkel FC, Shevchenko A, Mann M, Krammer PH, Peter ME: FLICE is activated by association with the CD95 death-inducing signaling complex (DISC). EMBO J 16:2794, 1997
30. Giri DK, Aggarwal BB: Constitutive activation of NF-κB causes resistance to apoptosis in human cutaneous T-cell lymphoma HuT-78 cells: Autocrine role of tumor necrosis factor and reactive oxygen intermediates. J Biol Chem 273:14008, 1998
31. Sekine C, Yagita H, Kobata T, Hasunuma T, Nishioka K, Okumura K: Fas-mediated stimulation induces IL-8 secretion by rheumatoid arthritis synoviocytes independently of CPP32-mediated apoptosis. Biophys Biochem Res Commun 228:14, 1996
32. Yeh J-H, Hsu S-C, Han S-H, Lai M-Z: Mitogen-activated protein kinase kinase antagonized Fas-associated death domain protein-mediated apoptosis by induced FLICE-inhibitory protein expression. J Exp Med 188:1795, 1998
33. Watanabe-Fukunaga R, Brannan CI, Copeland NG, Jenkins NA, Nagata S: Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356:314, 1992
34. Takahashi T, Tanaka M, Brannan CI, Jenkins NA, Copeland NG, Suda T, Nagata S: Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 76:969, 1994
35. White E, Sabbatini P, Debbas M, Wold WS, Kusher DI, Gooding LR: The 19-kilodalton adenovirus E1B transforming protein inhibits programmed cell death and prevents cytolysis by tumor necrosis factor alpha. Mol Cell Biol 12:2570, 1992
36. Henderson S, Huen D, Rowe M, Dawson C, Johnson G, Rickinson A: Epstein-Barr virus-coded BHRF1 protein, a viral homologue of Bcl-2, protects human B cells from programmed cell death. Proc Natl Acad Sci USA 90:8479, 1993
37. Green JE, Hinrichs SH, Vogel J, Jay G: Exocrinopathy resembling Sjögren's syndrome in HTLV-I tax transgenic mice. Nature 341:72, 1989
38. Iwakura Y, Tosu M, Yoshida E, Takiguchi M, Sato K, Kitajima I, Nishioka K, Yamamoto K, Takeda T, Hatanaka M, Yamamoto H, Sekiguchi T: Induction of inflammatory arthropathy resembling rheumatoid arthritis in mice transgenic for HTLV-I. Science 253:1026, 1991